New Illumina MiSeq Service Agreement

The Food and Drug Administration is forecasting a new service agreement to procure Illumina MiSeq sequencing services for micro surveillance applications, with the opportunity posted on May 25, 2026. The contract falls under NAICS code 811219, indicating it is related to other commercial and industrial machinery and equipment repair and maintenance, and is intended to support critical analytical and monitoring functions within the agency’s public health surveillance infrastructure. While the specific scope of work is not detailed in the posting, the use of Illumina MiSeq technology implies a focus on high-throughput genetic sequencing to detect and track microbial pathogens, potentially for food safety, environmental monitoring, or regulatory compliance purposes. The point of contact for program inquiries is the Nctr Acquisition Liaison, reachable at nctracquisitions@fda.hhs.gov, while the contracting officer position is listed as to be determined. The place of performance and office address details are currently unspecified, suggesting that the final location for service delivery has not been confirmed. This forecast is posted on the HHS OSDBU database, indicating early-stage planning with no formal solicitation issued yet, and no set-aside provisions are indicated. Interested vendors should monitor for a future formal release of solicitation details to prepare proposals aligned with FDA's regulatory and technical requirements for genomic surveillance.